MDGL vs. IMVT
Compare and contrast key facts about Madrigal Pharmaceuticals, Inc. (MDGL) and Immunovant, Inc. (IMVT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MDGL or IMVT.
Key characteristics
| MDGL | IMVT | |
|---|---|---|
| YTD Return | 46.53% | -30.52% |
| 1Y Return | 132.22% | -10.76% |
| 3Y Return (Ann) | 55.39% | 50.96% |
| 5Y Return (Ann) | 28.08% | 23.60% |
| Sharpe Ratio | 2.18 | -0.22 |
| Sortino Ratio | 2.84 | 0.01 |
| Omega Ratio | 1.36 | 1.00 |
| Calmar Ratio | 2.24 | -0.20 |
| Martin Ratio | 9.49 | -0.36 |
| Ulcer Index | 15.19% | 28.84% |
| Daily Std Dev | 66.00% | 47.61% |
| Max Drawdown | -98.40% | -93.59% |
| Current Drawdown | -17.28% | -44.47% |
Fundamentals
| MDGL | IMVT | |
|---|---|---|
| Market Cap | $7.39B | $4.30B |
| EPS | -$25.04 | -$2.21 |
| Total Revenue (TTM) | $77.58M | $1.50M |
| Gross Profit (TTM) | $74.22M | $1.30M |
| EBITDA (TTM) | -$547.48M | -$335.58M |
Correlation
The correlation between MDGL and IMVT is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MDGL vs. IMVT - Performance Comparison
In the year-to-date period, MDGL achieves a 46.53% return, which is significantly higher than IMVT's -30.52% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MDGL vs. IMVT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Madrigal Pharmaceuticals, Inc. (MDGL) and Immunovant, Inc. (IMVT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MDGL vs. IMVT - Dividend Comparison
Neither MDGL nor IMVT has paid dividends to shareholders.
Drawdowns
MDGL vs. IMVT - Drawdown Comparison
The maximum MDGL drawdown since its inception was -98.40%, which is greater than IMVT's maximum drawdown of -93.59%. Use the drawdown chart below to compare losses from any high point for MDGL and IMVT. For additional features, visit the drawdowns tool.
Volatility
MDGL vs. IMVT - Volatility Comparison
Madrigal Pharmaceuticals, Inc. (MDGL) has a higher volatility of 28.47% compared to Immunovant, Inc. (IMVT) at 11.42%. This indicates that MDGL's price experiences larger fluctuations and is considered to be riskier than IMVT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MDGL vs. IMVT - Financials Comparison
This section allows you to compare key financial metrics between Madrigal Pharmaceuticals, Inc. and Immunovant, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities